Skip to main content

Table 2 SPER, DASPER, and RESPER for the top candidates with DASPER > 0 and RESPER > 1 across all prostate cancer tissue samples

From: FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data

Type ID Fusion candidate SPER DASPER RESPER
Intra 580_B TMPRSS2-ERG 36.54 36.53 14.31
Intra 1700_D TMPRSS2-ERG 19.66 19.63 8.79
Intra 106_T TMPRSS2-ERG 10.16 10.11 3.97
Inter 2621_D SLC45A3-ERG 4.29 4.15 3.56
Inter 1700_D ERG-GMPR 4.59 4.59 2.05
Read-through 1700_D SLC16A8-BAIAP2L2 4.33 4.33 1.93
Read-through 106_T AK094188-AK311452 4.87 4.87 1.9
Read-through 1700_D ZNF473-FLJ26850 3.54 3.54 1.58
Read-through 580_B ZNF577-FLJ26850 4.03 4.03 1.58
Read-through 1043_D ZNF577-ZNF649 5.79 5.79 1.55
Read-through 1700_D CAMTA2-INCA1 3.01 3.01 1.35
Inter 1700_D EEF1D-HDAC5 2.88 2.84 1.29
Read-through 1043_D FLJ00248-LRCH4 4.74 4.74 1.27
Read-through 1700_D VMAC-CAPS 2.62 2.62 1.17
Read-through 106_T FLJ00248-LRCH4 2.96 2.96 1.16
Cis 1043_D AX747861-FLI1 4.21 4.21 1.13
Read-through 106_T TAGLN-AK126420 2.75 2.75 1.07
Inter 580_B PIGU-ALG5 2.73 2.73 1.07
Inter 99_T NDRG1-ERG 7.26 7.15 1.02
  1. Cell lines are reported in Table S1 in Additional file 1. Entries in bold are known gene fusions, and those in italics read-through events confirmed either experimentally or via additional evidence, such as ESTs or mRNAs from GenBank.